Cancer Industrial Complex: Big Pharma’s Cash Cow Meets Ivermectin’s Low Cost Effectiveness
For years, ivermectin has been one of the most controversial words in medicine. First it was COVID. Now it’s cancer. It’s also inexpensive, which doesn’t excite Big Pharma, unless to alarm people by calling it horse dewormer medication. According to Dr. David Rasnick, author of the new book The Outsider: A Personal Odyssey into the Essence of Cancer, Ivermectin as a legitimate treatment for cancer is very real and Chemotherapy does to cancer patients what ventilators and Remdesivir did for what we were told was the COVID virus.
- Ivermectin gains attention as cancer patients seek alternatives.
- Warburg Effect may explain cancer’s metabolic origins.
- Chemotherapy toxicity is detrimental to patients
- Medical establishment resists challenges to cancer orthodoxy.
- Dr. Rasnick claims cancer’s true cause is misunderstood.
A growing number of cancer patients are reportedly turning to ivermectin instead of conventional chemotherapy, alarming oncologists and prompting major media coverage. Recent reports highlight patients who believe the inexpensive anti-parasitic drug may offer benefits against cancer, while mainstream medical experts warn there is insufficient clinical evidence to support such use. Prescriptions among cancer patients have reportedly surged in recent years as public interest continues to grow.
Dr. David Rasnick isn’t surprised.
The veteran biochemist, cancer researcher, and author of The Outsider argues that the real story isn’t ivermectin—it’s why so many Americans are losing confidence in conventional cancer treatment in the first place.
According to Rasnick, the discussion should begin with the metabolic nature of cancer itself. He points to the work of Nobel Prize-winning scientist Otto Warburg, whose research found that cancer cells exhibit abnormal glucose metabolism, commonly known as the Warburg Effect. The phenomenon remains widely recognized in cancer biology today.
Rasnick contends that ivermectin’s potential role in addressing metabolic dysfunction deserves serious investigation rather than reflexive dismissal. He believes the drug’s emerging popularity reflects growing public frustration with a cancer-treatment paradigm that often relies heavily on chemotherapy, radiation, and highly toxic interventions.
Even more provocatively, Rasnick argues that modern oncology is focused on treating symptoms rather than causes. He maintains that cancer is fundamentally misunderstood by much of the medical establishment and that he has spent decades studying what he believes are the true biological mechanisms behind the disease.
His critiques extend beyond cancer. During the COVID era, Rasnick openly challenged prevailing narratives surrounding both the virus and the medical response, drawing parallels between what he views as dangerous groupthink during the pandemic and current resistance to alternative cancer therapies.
Whether one agrees with him or not, Rasnick offers a perspective rarely heard in mainstream media: a scientist willing to challenge accepted assumptions about cancer, chemotherapy, ivermectin, and the incentives that drive modern medicine.
At a time when patients are increasingly searching for alternatives and asking difficult questions, Dr. David Rasnick can explain why the debate over ivermectin a debate over the future of cancer treatment itself is really.
Relevant Article(s):
Cancer patients are choosing ivermectin over chemo, and doctors are concerned | WGN-TV
OPTIONAL Q&A:
- Why are cancer patients increasingly rejecting conventional chemotherapy?
- What is the Warburg Effect, and why is it so important?
- Could cancer be primarily a metabolic disease rather than a genetic one?
- What evidence suggests ivermectin may have anti-cancer properties?
- Why does the medical establishment resist alternative cancer treatments?
- What does Dr. Rasnick believe is the actual cause of cancer?
- How should cancer treatment change if current assumptions are wrong?
- What parallels does Dr. Rasnick see between COVID-era medicine and oncology today?
ABOUT DAVID RASNICK…
David Rasnick has a PhD in chemistry from the Georgia Institute of Technology. In 1996, he joined Peter Duesberg at the University of California at Berkeley, where they proved the hundred-year old theory that unbalanced chromosomes cause cancer. He was a named contributing editor to explosive book by Robert F. Kennedy, JR. The Real Anthony Fauci.
For nearly two decades, Rasnick developed inhibitors of enzymes responsible for the tissue destruction caused by arthritis, emphysema, parasites, and cancer. His 2012 book, The Chromosomal Imbalance Theory of Cancer: Autocatalyzed Progression of Aneuploidy is Carcinogenesis, is for cancer researchers. His new book, The Outsider’s Advantage: A Personal Odyssey into the Essence of Cancer, tells the same story but in plain language and in the context of his decades-long journey as an outsider.
TO SCHEDULE AN INTERVIEW, CALL OR TEXT 512-966-0983 OR EMAIL BOOKINGS@SPECIALGUESTS.COM
